z-logo
open-access-imgOpen Access
MiR-17 and miR-93 Promote Tumor Progression by Targeting p21 in Patients with Chordoma
Author(s) -
Wei Dong,
Jingwu Li,
Xiaoliu Dong,
Wenjian Shi,
Yu Zhang,
Yongliang Liu
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s307138
Subject(s) - chordoma , microrna , cancer research , cell growth , biomarker , biology , medicine , pathology , gene , genetics
MicroRNAs have been implicated in the progression of various cancers. However, the role of microRNAs in chordoma remains to be further elucidated. Here, we purposed to character the role of two microRNAs, miR-17 and miR-93, and their potential mechanisms in chordoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here